[1]

国家心血管病中心. 中国心血管健康与疾病报告2022[M]. 北京: 中国协和医科大学出版社, 2023.

National Center for Cardiovascular Diseases. Annual report on cardiovascular health and diseases in China (2022)[M]. Beijing: Peking Union Medical College Press, 2023.
[2] Knuuti J, Wijns W, Saraste A, et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3): 407-477.   doi: 10.1093/eurheartj/ehz425
[3] 中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等.  稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694.   doi: 10.3760/cma.j.issn.0253-3758.2018.09.004
Section of Interventional Cardiology of Chinese Society of Cardiology, Section of Atherosclerosis and Coronary Artery Disease of Chinese Society of Cardiology, Specialty Committee on Prevention and Treatment of Thrombosis of Chinese College of Cardiovascular Physicians, et al.  Guideline on the diagnosis and treatment of stable coronary artery disease[J]. Chin J Cardiol, 2018, 46(9): 680-694.   doi: 10.3760/cma.j.issn.0253-3758.2018.09.004
[4] Tonino PAL, De Bruyne B, Pijls NHJ, et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention[J]. N Engl J Med, 2009, 360(3): 213-224.   doi: 10.1056/NEJMoa0807611
[5] Berry C, Layland J, Sood A, et al.  Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial[J]. Am Heart J, 2013, 166(4): 662-668.e3.   doi: 10.1016/j.ahj.2013.07.011
[6] Sun RX, Ma RZ, Wang M, et al.  Prognostic value of myocardial flow reserve derived by quantitative SPECT for patients with intermediate coronary stenoses[J]. J Nucl Cardiol, 2023, 30(4): 1427-1436.   doi: 10.1007/s12350-022-03186-z
[7] Agostini D, Roule V, Nganoa C, et al.  First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study[J]. Eur J Nucl Med Mol Imaging, 2018, 45(7): 1079-1090.   doi: 10.1007/s00259-018-3958-7
[8] Namdar M, Rager O, Priamo J, et al.  Prognostic value of revascularising viable myocardium in elderly patients with stable coronary artery disease and left ventricular dysfunction: a PET/CT study[J]. Int J Cardiovasc Imaging, 2018, 34(10): 1673-1678.   doi: 10.1007/s10554-018-1380-7
[9] 中华医学会核医学分会, 中华医学会心血管病学分会.  核素心肌显像临床应用指南(2018)[J]. 中华心血管病杂志, 2019, 47(7): 519-527.   doi: 10.3760/cma.j.issn.0253-3758.2019.07.003
Society of Nuclear Medicine of Chinese Medical Association, Society of Cardiology of Chinese Medical Association.  Guideline for the clinical use of myocardial radionuclide imaging (2018)[J]. Chin J Cardiol, 2019, 47(7): 519-527.   doi: 10.3760/cma.j.issn.0253-3758.2019.07.003
[10] Abraham A, Nichol G, Williams KA, et al.  18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial[J]. J Nucl Med, 2010, 51(4): 567-574.   doi: 10.2967/jnumed.109.065938
[11] Panza JA, Ellis AM, Al-Khalidi HR, et al.  Myocardial viability and long-term outcomes in ischemic cardiomyopathy[J]. N Engl J Med, 2019, 381(8): 739-748.   doi: 10.1056/NEJMoa1807365
[12] Ponikowski P, Voors AA, Anker SD, et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2016, 37(27): 2129-2200.   doi: 10.1093/eurheartj/ehw128